JAK2 and myeloproliferative neoplasm: The biologic basis for this behavior appears to be due to JAK2-mutant MPN driver mutations being acquired apparently randomly both in utero and throughout life with an estimated mean latency of 30 years (range, 11–54 years) between driver gene mutation acquisition and diagnosis [73,74].